The National Institute of General Medical Sciences (NIGMS) awarded a $1,117,500 Project Grant under the Biomedical Research and Research Training Program (CFDA 93.859) to the University of South Carolina (USC) to establish and sustain the Center for Targeted Therapeutics (CTT). The CTT supports high-impact research projects in targeted therapeutics, maintains sustainable research infrastructure through core facilities, and promotes collaborative networking to advance the field of targeted...
The National Institute of General Medical Sciences (NIGMS) awarded a $2,179,141 Project Grant (CFDA 93.859 - Biomedical Research and Research Training) to the University of Montana to establish the Montana Clinical and Translational Research Center (Montana CTRC). The goal of the Montana CTRC is to build clinical and translational research capacity in Montana's rural and underserved communities. Key objectives include: Providing mentorship and professional development to enhance the capacity and...
This federal Cooperative Agreement award, provided by the National Center for Advancing Translational Sciences (NCATS) under CFDA Program 93.350, supports the South Carolina Clinical & Translational Research Institute (SCTR) at the Medical University of South Carolina (MUSC). The $3,809,664 award, effective from April 2025 through March 2032, will strengthen SCTR's community-engaged, patient-focused clinical and translational science (CTS) infrastructure across South Carolina. Key objectives...
This $1,116,183 federal Project Grant award was provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) to the University of South Carolina (USC) from July 15, 2024 to May 31, 2029. The funding supports the Center for Dietary Supplements and Inflammation (CDSI) at USC, which conducts research on how compounds derived from botanicals and natural products can attenuate inflammation and understand the...
The University of Southern California (USC) has been awarded a $221,904 Project Grant from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310). The five-year grant, effective September 1, 2024, will fund the "Advance Cancer Health Disparities Research (CHDR) Training Program" at USC. The program aims to enhance the knowledge, skills, and research capacity of pre-doctoral students in minority health and cancer...
The National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) has awarded a $1,132,500 Project Grant to the Medical University of South Carolina (MUSC) for the period of August 1, 2024 to July 31, 2029. The grant supports MUSC's efforts to optimize and expand its established stroke recovery research programs, as well as to develop new strategies for advancing research excellence in the broader restoration of neural-based function....
This $2,336,825 Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) aims to build an impactful clinical and translational research program at the University of Louisville (UofL) to improve the health of Kentucky communities. The key objectives are to: 1) Expand and integrate clinical and translational research at UofL, UofL Healthcare, and other partners; 2) Provide professional development for...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $1,998,484 Cooperative Agreement to the University of South Carolina (USC) under the Assistance Programs for Chronic Disease Prevention and Control (CFDA 93.945) program. The award, effective September 30, 2024 through September 29, 2029, will support USC's "THE USC PRC: COMMUNITY-BASED PARTICIPATORY RESEARCH TO STUDY CHURCH IMPLEMENTATION OF AN EVIDENCE-BASED SOCIAL SUPPORT INTERVENTION TO INCREASE PHYSICAL ACTIVITY...
The National Institutes of Health (NIH) National Institute of General Medical Sciences (NIGMS) awarded a 5-year, $138,334 Project Grant (CFDA 93.859 - Biomedical Research and Research Training) to the University of Southern California (USC) to develop a scalable computational platform for ligand discovery. The research aims to combine structure-based and data-driven approaches to enable rapid identification of selective and potent ligands for novel therapeutic targets across areas like pain,...
The University of South Carolina (USC) was awarded a $400,000 five-year Cooperative Agreement (August 1, 2024 - July 31, 2029) under the Centers for Disease Control and Prevention (CDC) Collaboration with Academia to Strengthen Public Health program (CFDA 93.967). This federal grant will support USC in developing and strengthening public health infrastructure, workforce capabilities, and data systems across South Carolina. Funded activities will focus on workforce development, training,...